LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
Jun 17, 2018
Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series
Jan 01, 2018
Heart Failure Management: Exploring Best Practices for the Internist
Sep 26, 2017
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
Apr 08, 2017
The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies
Nov 08, 2016
The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies
Mar 14, 2015
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
January 01, 2018
An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol
September 26, 2017
Experts Dr. Javed Butler and Dr. James Januzzi provide helpful insights on the topic of Heart Failure and offer best practices on heart failure management.
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
No Credit Available
November 08, 2016
In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.
March 14, 2015
Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.